ClinicalTrials.gg
RecruitingNCT07716319Updated Nov 10, 2026

Comparison Between Eccentric Hamstring Training and Sprint-Specific Training

An interventional study of RDL and NHE in Healthy Adult, Athlete and Exercise Training, sponsored by University of Wisconsin, Madison. Recruiting at 1 site in United States. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Nov 10, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The purpose of this study is to compare the effects of an intensity-, volume-, and time under tension-matched eccentric hamstring exercise intervention with the Romanian deadlift (RDL) and the Nordic hamstring exercise (NHE) to a sprint-specific training program on hamstring muscle architecture, volume, sprint performance, strength, and power.

Participants will be assigned to complete one of the 3 hamstring interventions for 10 weeks.

Read the detailed description

Prior to the intervention, participants will undergo baseline testing which will include a) ultrasound imaging of the hamstrings muscles for measures of biceps femoris long head fascicle length, pennation angle, muscle thickness, anatomical cross-sectional area, and muscle volume b) passive and active ranges of motion, c) 3 repetition maximum (3RM) RDL strength, d) peak NHE force, e) countermovement jump height, f) broad jump distance, g) Pro Agility change of direction, and h) a 60 m sprint with sprint kinematics assessed via inertial measurement units.

Participants will be randomly assigned to either the RDL, NHE, or sprint training group. After randomization, each participant will undergo the intervention program based upon their group allocation.

Performance testing and imaging will be repeated mid-intervention, following the intervention, and after 2 weeks of deloading.

02

Conditions studied

  • Healthy Adult
  • Athlete
  • Exercise Training
  • Sport
  • Running
  • Ultrasound Imaging

Browse trials for

Keywords

  • strength
  • agility
  • sprint
  • hypertrophy
  • countermovement jump
  • fascicle length
  • hamstring
  • range of motion
03

In context

Hypertrophy

139 studies on the registry are indexed under Hypertrophy; 22 are open to participants now.

This study's planned enrollment of 90 is above the median of 34 across 112 interventional studies indexed under Hypertrophy.

Browse Hypertrophy studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,188 studies on the registry; 181 are open to participants now.

Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-25 years
  • Actively participating in a club team
  • >6 months experience with resistance training
  • Minimum of 1 year experience at the high school level in organized team sport
  • No history of hamstring injury within the last 6 months
  • No history of major lower extremity surgery (including back)
  • No acute musculoskeletal injury to the lower extremity
  • Not currently pregnant

Exclusion criteria

Exclusion Criteria:

  • Unable to refrain from resistance training outside the study
  • Unable to make at least 80% of the training sessions
  • Hamstring injury in the last 6 months
  • History of major lower extremity surgery (including back)
  • Acute musculoskeletal injury to the lower extremity
  • Currently pregnant
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Romanian dead lift (RDL) group

    The training intervention groups will undergo the same program with the only difference being the interventional hamstring exercise. The program will consist of a 2-week familiarization period followed by 8 weeks of progressive training. The RDL arm will perform RDL.

    Other: RDL

  • Experimental
    Nordic hamstring exercise (NHE) group

    The training intervention groups will undergo the same program with the only difference being the interventional hamstring exercise. The program will consist of a 2-week familiarization period followed by 8 weeks of progressive training. The NHE arm will performed NHE

    Other: NHE

  • Experimental
    Sprint group

    The training intervention groups will undergo the same program with the only difference being the interventional hamstring exercise. The program will consist of a 2-week familiarization period followed by 8 weeks of progressive training. The sprint training program will be performed twice per week with the first day of training focused on shorter distances to focus on acceleration and the second training day focused on maximal velocity. The relative efforts and distances for each training day will mimic a similar prescription to that of the resistance training program.

    Other: Sprint testing

Interventions

  • OtherRDL

    The RDL will be performed with a 6 second eccentric component with the athlete returning to the start position with a maximal concentric hip extension.

  • OtherNHE

    The NHE will be performed with a 6 second eccentric component.

  • OtherSprint testing

    The sprint training program will be performed twice per week with the first day of training focused on shorter distances to focus on acceleration and the second training day focused on maximal velocity. The relative efforts and distances for each training day will mimic a similar prescription to that of the resistance training program.

06

What researchers measure

Primary outcomes

  1. Change in fascicle length (FL)

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  2. Change in muscle cross-sectional area (CSA)

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  3. Change in muscle volume

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  4. Change in pennation angle (PA)

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

Secondary outcomes

  1. Change in eccentric strength

    Eccentric hamstring strength of each limb will be assessed during the hamstring exercise.

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  2. Change in inertial measurement units (IMU)-based sprinting biomechanics

    Sprinting biomechanics will be assessed using seven IMUs (sacrum, both thighs, both shanks, both feet). Lower extremity joint motions referenced to upright stance will be calculated throughout an on-field sprint and other football drills.

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  3. Change in countermovement jump (CMJ) performance

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  4. Change in standing broad jump (SBJ) performance

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  5. Change in change of direction (CoD) performance

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  6. Change in range of motion (ROM) performance

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  7. Change in hip flexion

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

  8. Change in anterior pelvic tilt

    Time frame: Baseline to Mid-intervention (6 weeks), Post-intervention (10 weeks), and Post 2 week de-training (12 weeks)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Sep 2027, 13 months after the start.

Of 65 non-industry interventional studies with no phase under Hypertrophy, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 22. This study's planned 13 months is below that.

Counting every sponsor, half of 78 studies reached it within 13 months; a quarter within 6 and three quarters within 22.

Start moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Aug 2026, last on Nov 10, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 7, 2026
First posted
Jul 21, 2026
StartActual
Aug 28, 2026was Sep 2026
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 10, 2026
Sites
University of Wisconsin - Madison is now Recruiting
Nov 10, 2026
Start date
Sep 2026→Aug 28, 2026 (actual)
moved 2 times, Sep 29, 2026 – Nov 10, 2026
Show all 2 updates
  1. Nov 10, 2026
    Not yet recruiting→Recruiting
    University of Wisconsin - Madison is now Recruiting
    Start date Oct 2026→Aug 28, 2026 (now actual)
  2. Sep 29, 2026
    Start date Sep 2026→Oct 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07716319
Collaborators
National Strength and Conditioning Association (NSCA) Foundation
Responsible party
Sponsor
First posted
Jul 21, 2026
Start date
Aug 28, 2026
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Scott K Crawford, PhD
Contact
skcrawford2@wisc.edu
608) 265-1308

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion